Fyn kinase function in lipid utilization: A new upstream regulator of AMPK activity?

Archives of Physiology and Biochemistry

Volumn 115, Issue 4, 2009, Pages 191-198

  Vatish, Manu ^a,b   Yamada, Eijiro ^a   Pessin, Jeffrey E ^a   Bastie, Claire C ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF WARWICK   (United Kingdom)

Author keywords

AMPK; Fyn kinase; Homeostasis; Lipid metabolism; LKB1

Indexed keywords

ADENYLATE KINASE; FYN PROTEIN, HUMAN; INSULIN; PROTEIN KINASE FYN;

CHEMISTRY; HUMAN; LIPID METABOLISM; METABOLISM; OXIDATION REDUCTION REACTION; PROTEIN CONFORMATION; REVIEW; SIGNAL TRANSDUCTION;

ADENYLATE KINASE; HUMANS; INSULIN; LIPID METABOLISM; OXIDATION-REDUCTION; PROTEIN CONFORMATION; PROTO-ONCOGENE PROTEINS C-FYN; SIGNAL TRANSDUCTION;

EID: 70449365855     PISSN: 13813455     EISSN: 17444160     Source Type: Journal    
DOI: 10.1080/13813450903164348     Document Type: Review

References (82)

1. Alessi DR, Sakamoto K, Bayascas JR. (2006). LKB1-dependent signalling pathways. Annu Rev Biochem 75:137-163
2. Asante-Appiah E, Kennedy BP. (2003). Protein tyrosine phosphatases: the quest for negative regulators of insulin action. Am J Physiol Endocrinol Metab 284:E663-70.
3. Baas AF, Boudeau J, Sapkota GP, Smit L, Medema R, Morrice NA, Alessi DR, Clevers HC. (2003). Activation of the tumour suppressor kinase LKB1 by the STE20-like pseudokinase STRAD. EMBO J 22:3062-3072
4. Bastie CC, Zong H, Xu J, Busa B, Judex S, Kurland IJ, Pessin JE. (2007). Integrative metabolic regulation of peripheral tissue fatty acid oxidation by the SRC kinase family member Fyn. Cell Metab 5:371-381
5. Boggon TJ, Eck MJ. (2004). Structure and regulation of Src family kinases. Oncogene 23:7918-7927
6. Boudeau J, Baas AF, Deak M, Morrice NA, Kieloch A, Schutkowski M, Prescott AR, Clevers HC, Alessi DR. (2003). MO25alpha/beta interact with STRADalpha/beta enhancing their ability to bind, activate and localize LKB1 in the cytoplasm. EMBO J 22:5102-5114
7. Brown MT, Cooper JA. (1996). Regulation, substrates and functions of src. Biochim Biophys Acta 1287:121-149
8. Bull HA, Brickell PM, Dowd PM. (1994). Src-related protein tyrosine kinases are physically associated with the surface antigen CD36 in human dermal microvascular endothelial cells. FEBS Lett 351: 41-44
9. Capozza F, Combs TP, Cohen AW, Cho YR, Park SY, Schubert W, Williams TM, Brasaemle DL, Jelicks LA, Scherer PE, Kim JK, Lisanti MP. (2005). Caveolin-3 knockout mice show increased adiposity and whole body insulin resistance, with ligandinduced insulin receptor instability in skeletal muscle. Am J Physiol Cell Physiol 288:C1317-31.
10. Chan AC, Desai DM, and Weiss A. (1994). The role of protein tyrosine kinases and protein tyrosine phosphatases in T cell antigen receptor signal transduction. Annu Rev Immunol 12:555-592
11. Chong YP, Ia KK, Mulhern TD, and Cheng HC. (2005a). Endogenous and synthetic inhibitors of the Src-family protein tyrosine kinases. Biochim Biophys Acta 1754:210-220
12. Chong YP, Mulhern TD, Cheng HC. (2005b). C-terminal Src kinase (CSK) and CSK-homologous kinase (CHK)-endogenous negative regulators of Src-family protein kinases. Growth Factors 23:233-244
13. Chong YP, Mulhern TD, Zhu HJ, Fujita DJ, Bjorge JD, Tantiongco JP, Sotirellis N, Lio DS, Scholz G, Cheng HC. (2004). A novel non-catalytic mechanism employed by the C-terminal Srchomologous kinase to inhibit Src-family kinase activity. J Biol Chem 279:20752-20766
14. Choudhury GG, Mahimainathan L, Das F, Venkatesan B, and Ghosh-Choudhury N. (2006). c-Src couples PI 3 kinase/Akt and MAPK signalling to PDGF-induced DNA synthesis in mesangial cells. Cell Signal 18:1854-1864
15. Christofk HR, Vander Heiden MG, Harris MH, Ramanathan A, Gerszten RE, Wei R, Fleming MD, Schreiber SL, Cantley LC. (2008a). The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth. Nature 452:230-233
16. Christofk HR, Vander Heiden MG, Wu N, Asara JM, and Cantley LC. (2008b). Pyruvate kinase M2 is a phosphotyrosine- binding protein. Nature 452:181-186
17. Chung AB, Stepien G, Haraguchi Y, Li K, Wallace DC. (1992). Transcriptional control of nuclear genes for the mitochondrial muscle ADP/ATP translocator and the ATP synthase beta subunit. Multiple factors interact with the OXBOX/ REBOX promoter sequences. J Biol Chem 267:21154-21161
18. Cohen AW, Razani B, Wang XB, Combs TP, Williams TM, Scherer PE, Lisanti MP. (2003). Caveolin-1-deficient mice show insulin resistance and defective insulin receptor protein expression in adipose tissue. Am J Physiol Cell Physiol 285:C222-35.
19. Collins SP, Reoma JL, Gamm DM, Uhler MD. (2000). LKB1, a novel serine/threonine protein kinase and potential tumour suppressor, is phosphorylated by cAMP-dependent protein kinase (PKA) and prenylated in vivo. Biochem J 345 Pt 3:673-680
20. Colognato H, Ramachandrappa S, Olsen IM, ffrench-Constant C. (2004). Integrins direct Src family kinases to regulate distinct phases of oligodendrocyte development. J Cell Biol 167:365-375
21. Cooke MP, Perlmutter RM. (1989). Expression of a novel form of the fyn proto-oncogene in hematopoietic cells. New Biol 1:66-74.
22. Davies SP, Hawley SA, Woods A, Carling D, Haystead TA, Hardie DG. (1994). Purification of the AMP-activated protein kinase on ATP-gamma-sepharose and analysis of its subunit structure. Eur J Biochem 223:351-357
23. Davies SP, Helps NR, Cohen PT, Hardie DG. (1995). 5-AMP inhibits dephosphorylation, as well as promoting phosphorylation, of the AMP-activated protein kinase. Studies using bacterially expressed human protein phosphatase-2C alpha and native bovine protein phosphatase-2AC. FEBS Lett 377:421-425
24. Della Rocca GJ, van Biesen T, Daaka Y, Luttrell DK, Luttrell LM, Lefkowitz RJ. (1997). Ras-dependent mitogen-activated protein kinase activation by G protein-coupled receptors. Convergence of Gi- and Gq-mediated pathways on calcium/calmodulin, Pyk2, and Src kinase. J Biol Chem 272:19125-19132
25. Drover VA, Abumrad NA. (2005). CD36-dependent fatty acid uptake regulates expression of peroxisome proliferator activated receptors. Biochem Soc Trans 33:311-315
26. Ebert BL, Firth JD, Ratcliffe PJ. (1995). Hypoxia and mitochondrial inhibitors regulate expression of glucose transporter-1 via distinct Cis-acting sequences. J Biol Chem 270:29083-29089
27. Gadue P, Yin L, Jain S, Stein PL. (2004). Restoration of NK T cell development in fyn-mutant mice by a TCR reveals a requirement for Fyn during early NK T cell ontogeny. J Immunol 172:6093-6100
28. Goldsmith JF, Hall CG, Atkinson TP. (2002). Identification of an alternatively spliced isoform of the fyn tyrosine kinase. Biochem Biophys Res Commun 298:501-504
29. Hardie DG, Hawley SA. (2001). AMP-activated protein kinase: the energy charge hypothesis revisited. Bioessays 23:1112-1119
30. Hardie DG, Salt IP, Hawley SA, Davies SP. (1999). AMP-activated protein kinase: An ultrasensitive system for monitoring cellular energy charge. Biochem J 338 (Pt 3):717-722
31. Hawley SA, Boudeau J, Reid JL, Mustard KJ, Udd L, Makela TP, Alessi DR, Hardie DG. (2003). Complexes between the LKB1 tumor suppressor, STRAD alpha/beta and MO25 alpha/beta are upstream kinases in the AMP-activated protein kinase cascade. J Biol 2:28.
32. Hawley SA, Gadalla AE, Olsen GS, Hardie DG. (2002). The antidiabetic drug metformin activates the AMP-activated protein kinase cascade via an adenine nucleotide-independent mechanism. Diabetes 51:2420-2425
33. Hawley SA, Pan DA, Mustard KJ, Ross L, Bain J, Edelman AM, Frenguelli BG, Hardie DG. (2005). Calmodulin-dependent protein kinase kinase-beta is an alternative upstream kinase for AMP-activated protein kinase. Cell Metab 2:9-19.
34. Hawley SA, Selbert MA, Goldstein EG, Edelman AM, Carling D, Hardie DG. (1995). 5-AMP activates the AMP-activated protein kinase cascade, and Ca2+/calmodulin activates the calmodulin-dependent protein kinase I cascade, via three independent mechanisms. J Biol Chem 270:27186-27191
35. Huang MM, Bolen JB, Barnwell JW, Shattil SJ, Brugge JS. (1991). Membrane glycoprotein IV (CD36) is physically associated with the Fyn, Lyn, and Yes protein-tyrosine kinases in human platelets. Proc Natl Acad Sci USA 88: 7844-7848
36. Kajita K, Mune T, Ikeda T, Matsumoto M, Uno Y, Sugiyama C, Matsubara K, Morita H, Takemura M, Seishima M, Takeda J, Ishizuka T. (2008). Effect of fasting on PPARgamma and AMPK activity in adipocytes. Diabetes Res Clin Pract 81:144-149
37. Kovacic S, Soltys CL, Barr AJ, Shiojima I, Walsh K, Dyck JR. (2003). Akt activity negatively regulates phosphorylation of AMP-activated protein kinase in the heart. J Biol Chem 278:39422-39427
38. Lage R, Dieguez C, Vidal-Puig A, Lopez M. (2008). AMPK: A metabolic gauge regulating whole-body energy homeostasis. Trends Mol Med 14:539-549
39. Liang X, Lu Y, Wilkes M, Neubert TA, Resh MD. (2004). The N-terminal SH4 region of the Src family kinase Fyn is modified by methylation and heterogeneous fatty acylation: role in membrane targeting, cell adhesion, and spreading. J Biol Chem 279:8133-8139
40. Liang X, Nazarian A, Erdjument-Bromage H, Bornmann W, Tempst P, Resh MD. (2001). Heterogeneous fatty acylation of Src family kinases with polyunsaturated fatty acids regulates raft localization and signal transduction. J Biol Chem 276:30987-30994
41. Luttrell LM, Daaka Y, Lefkowitz RJ. (1999). Regulation of tyrosine kinase cascades by G-protein-coupled receptors. Curr Opin Cell Biol 11:177-183
42. Marley AE, Sullivan JE, Carling D, Abbott WM, Smith GJ, Taylor IW, Carey F, Beri RK. (1996). Biochemical characterization and deletion analysis of recombinant human protein phosphatase 2C alpha. Biochem J 320 (Pt 3):801-806
43. Mastick CC, Saltiel AR. (1997). Insulin-stimulated tyrosine phosphorylation of caveolin is specific for the differentiated adipocyte phenotype in 3T3-L1 cells. J Biol Chem 272:20706-20714
44. Meex SJ, van der Kallen CJ, van Greevenbroek MM, Eurlings PM, El Hasnaoui M, Evelo CT, Lindsey PJ, Luiken JJ, Glatz JF, de Bruin TW. (2005). Up-regulation of CD36/FAT in preadipocytes in familial combined hyperlipidemia. FASEB J 19:2063-2065
45. Momcilovic M, Hong SP, Carlson M. (2006). Mammalian TAK1 activates Snf1 protein kinase in yeast and phosphorylates AMP-activated protein kinase in vitro. J Biol Chem 281:25336-25343
46. Muller G, Wied S, Frick W. (2000). Cross talk of pp125(FAK) and pp59(Lyn) non-receptor tyrosine kinases to insulin-mimetic signalling in adipocytes. Mol Cell Biol 20:4708-4723
47. Nada S, Okada M, MacAuley A, Cooper JA, Nakagawa H. (1991). Cloning of a complementary DNA for a protein-tyrosine kinase that specifically phosphorylates a negative regulatory site of p60c-src. Nature 351:69-72.
48. Newcomb LF, Mastick CC. (2002). Src family kinase-dependent phosphorylation of a 29-kDa caveolin-associated protein. Biochem Biophys Res Commun 290:1447-1453
49. Oshikawa J, Otsu K, Toya Y, Tsunematsu T, Hankins R, Kawabe J, Minamisawa S, Umemura S, Hagiwara Y, Ishikawa Y. (2004). Insulin resistance in skeletal muscles of caveolin-3-null mice. Proc Natl Acad Sci USA 101:12670-12675
50. Parravicini V, Gadina M, Kovarova M, Odom S, Gonzalez- Espinosa C, Furumoto Y, Saitoh S, Samelson LE, O'Shea JJ, Rivera J. (2002). Fyn kinase initiates complementary signals required for IgE-dependent mast cell degranulation. Nat Immunol 3:741-748
51. Perez MJ, Ortiz EH, Roffe M, Soto EF, Pasquini JM. (Forthcoming). Fyn kinase is involved in oligodendroglial cell differentiation induced by apotransferrin. J Neurosci Res.
52. Picard C, Gilles A, Pontarotti P, Olive D, Collette Y. (2002). Cutting edge: recruitment of the ancestral fyn gene during emergence of the adaptive immune system. J Immunol 168:2595-2598
53. Polekhina G, Gupta A, Michell BJ, van Denderen B, Murthy S, Feil SC, Jennings IG, Campbell DJ, Witters LA, Parker MW, Kemp BE, Stapleton D. (2003). AMPK beta subunit targets metabolic stress sensing to glycogen. Curr Biol 13:867-871
54. Poole AW, Jones ML. (2005). A SHPing tale: perspectives on the regulation of SHP-1 and SHP-2 tyrosine phosphatases by the C-terminal tail. Cell Signal 17:1323-1332
55. Pravenec M, Landa V, Zidek V, Musilova A, Kazdova L, Qi N, Wang J, St Lezin E, Kurtz TW. (2003). Transgenic expression of CD36 in the spontaneously hypertensive rat is associated with amelioration of metabolic disturbances but has no effect on hypertension. Physiol Res 52:681-688
56. Rafaeloff-Phail R, Ding L, Conner L, Yeh WK, McClure D, Guo H, Emerson K, Brooks H. (2004). Biochemical regulation of mammalian AMP-activated protein kinase activity by NAD and NADH. J Biol Chem 279:52934-52939
57. Roskoski Jr. R. (2005). Src kinase regulation by phosphorylation and dephosphorylation. Biochem Biophys Res Commun 331:1-14.
58. Salt I, Celler JW, Hawley SA, Prescot, A, Woods A, Carling D, Hardie DG. (1998). AMP-activated protein kinase: greater AMP dependence, and preferential nuclear localization, of complexes containing the alpha2 isoform. Biochem J 334 (Pt 1):177-187
59. Saltiel AR, Pessin JE. (2002). Insulin signalling pathways in time and space. Trends Cell Biol 12:65-71.
60. Saltiel AR, Pessin JE. (2003). Insulin signalling in microdomains of the plasma membrane. Traffic 4:711-716.
61. Sapkota GP, Kieloch A, Lizcano JM, Lain S, Arthur JS, Williams MR, Morrice N, Deak M, Alessi DR. (2001). Phosphorylation of the protein kinase mutated in Peutz-Jeghers cancer syndrome, LKB1/STK11, at Ser431 by p90(RSK) and cAMP- dependent protein kinase, but not its farnesylation at Cys(433), is essential for LKB1 to suppress cell growth. J Biol Chem 276:19469-19482
62. Sato I, Obata Y, Kasahara K, Nakayama Y, Fukumoto Y, Yamasaki T, Yokoyama KK, Saito T, Yamaguchi N. (2009). Differential trafficking of Src, Lyn, Yes and Fyn is specified by the state of palmitoylation in the SH4 domain. J Cell Sci 122:965-975
63. Sefton BM, Taddie JA. (1994). Role of tyrosine kinases in lymphocyte activation. Curr Opin Immunol 6:372-379
64. Sekimoto H, Boney CM. (2003). C-terminal Src kinase (CSK) modulates insulin-like growth factor-I signalling through Src in 3T3-L1 differentiation. Endocrinology 144:2546-2552
65. Sfeir Z, Ibrahimi A, Amri E, Grimaldi P, Abumrad N. (1999). CD36 antisense expression in 3T3-F442A preadipocytes. Mol Cell Biochem 192:3-8.
66. Shulman GI. (2000). Cellular mechanisms of insulin resistance. J Clin Invest 106:171-176
67. Sicheri F, Kuriyan J. (1997). Structures of Src-family tyrosine kinases. Curr Opin Struct Biol 7:777-785
68. Sim AT, Hardie DG. (1988). The low activity of acetyl-CoA carboxylase in basal and glucagon-stimulated hepatocytes is due to phosphorylation by the AMP-activated protein kinase and not cyclic AMP-dependent protein kinase. FEBS Lett 233:294-298
69. Stapleton D, Gao G, Michell BJ, Widmer J, Mitchelhill K, Teh T, House CM, Witters LA, Kemp BE. (1994). Mammalian 5-AMP-activated protein kinase non-catalytic subunits are homologs of proteins that interact with yeast Snf1 protein kinase. J Biol Chem 269:29343-29346
70. Sudol M, Greulich H, Newman L, Sarkar A, Sukegawa J, Yamamoto T. (1993). A novel Yes-related kinase, Yrk, is expressed at elevated levels in neural and hematopoietic tissues. Oncogene 8:823-831
71. Sun Y, Ma YC, Huang J, Chen KY, McGarrigle DK, Huang XY. (2005). Requirement of SRC-family tyrosine kinases in fat accumulation. Biochemistry 44:14455-14462
72. Takeuchi M, Kuramochi S, Fusaki N, Nada S, Kawamura- Tsuzuku J, Matsuda S, Semba K, Toyoshima K, Okada M, Yamamoto T. (1993). Functional and physical interaction of protein-tyrosine kinases Fyn and Csk in the T-cell signalling system. J Biol Chem 268:27413-27419
73. Tanaka T, Yamamoto J, Iwasaki S, Asaba H, Hamura H, Ikeda Y, Watanabe M, Magoori K, Ioka RX, Tachibana K, Watanabe Y, Uchiyama Y, Sumi K, Iguchi H, Ito S, Doi T, Hamakubo T, Naito M, Auwerx J, Yanagisawa M, Kodama T, Sakai J. (2003). Activation of peroxisome proliferator-activated receptor delta induces fatty acid beta-oxidation in skeletal muscle and attenuates metabolic syndrome. Proc Natl Acad Sci USA 100:15924-15929
74. van't Hof W, Resh MD. (1997). Rapid plasma membrane anchoring of newly synthesized p59fyn: selective requirement for NH2-terminal myristoylation and palmitoylation at cysteine-3. J Cell Biol 136:1023-1035
75. Woods A, Azzout-Marniche D, Foretz M, Stein SC, Lemarchand P, Ferre P, Foufelle F, Carling D. (2000). Characterization of the role of AMP-activated protein kinase in the regulation of glucose-activated gene expression using constitutively active and dominant negative forms of the kinase. Mol Cell Biol 20:6704-6711
76. Woods A, Cheung PC, Smith FC, Davison MD, Scott J, Beri RK, Carling D. (1996a). Characterization of AMP-activated protein kinase beta and gamma subunits. Assembly of the heterotrimeric complex in vitro. J Biol Chem 271:10282-10290
77. Woods A, Dickerson K, Heath R, Hong SP, Momcilovic M, Johnstone SR, Carlson M, Carling D. (2005). Ca2+/calmodulin- dependent protein kinase kinase-beta acts upstream of AMP-activated protein kinase in mammalian cells. Cell Metab 2:21-33.
78. Woods A, Salt I, Scott J, Hardie DG, Carling D. (1996b). The alpha1 and alpha2 isoforms of the AMP-activated protein kinase have similar activities in rat liver but exhibit differences in substrate specificity in vitro. FEBS Lett 397:347-351
79. Wu Y, Song P, Xu J, Zhang M, Zou MH. (2007). Activation of protein phosphatase 2A by palmitate inhibits AMP-activated protein kinase. J Biol Chem 282:9777-9788
80. Wullschleger S, Loewith R, Hall MN. (2006). TOR signalling in growth and metabolism. Cell 124:471-484
81. Xie M, Zhang D, Dyck JR, Li Y, Zhang H, Morishima M, Mann DL, Taffet GE, Baldini A, Khoury DS, Schneider MD. (2006). A pivotal role for endogenous TGF-beta-activated kinase-1 in the LKB1/AMP-activated protein kinase energy-sensor pathway. Proc Natl Acad Sci USA 103:17378-17383
82. Zheng XM, Resnick RJ, Shalloway D. (2000). A phosphotyrosine displacement mechanism for activation of Src by PTPalpha. EMBO J 19:964-978